The Philadelphia Women’s Center – which aborts over 6,000 babies a year (highest count for any one facility in the state) – has been the center of a lot of attention on both sides of the abortion argument. It has a lot of protests near or around it every weekend and has been the focus of a major documentary, Frontline: The Abortion Divide). Just recently, the 2020 inspection reports for the abortion clinic were posted on the PA Dept. of Health website. The Philadelphia Women’s Center failed, in both building safety matters and health procedure matters.
Below is a list of failures that I have summarized from the Philadelphia Women’s Center:
These were all reported in the Patient Care report that was filed.
- On 5 different occasions, a pediatric patient received an abortion, and signed for a drug called Misoprostol and Mifepristone, both of which required legal guardian or parental consent, and did not have it.
- On another occasion, a pediatric patient received the full medical abortion treatment without parental consent.
The scary thing about this is that this is where the facility failed. They were giving these pills to minors and allowing them to take it without parental or legal guardian consent, which is against the law.
The abortion pill itself is not without its own dangers. According to Live Action, 4 million preborn children have been chemically destroyed by this pill. There have additionally been 24 reported maternal deaths, and the FDA has received over 4,000 reports of adverse events from women experiencing hemorrhage, excruciating abdominal pain, and severe life-threatening infections. Since these adverse reactions are being broadcasted, not a lot of people know they could be putting themselves at risk during a medication abortion.
Here in the age of Covid-19, telemedicine is now one of the most popular ways to visit your doctor. This is also true in the abortion world. There is a massive push for telemedicine and online doctors’ visits, so that the women being prescribed the pill are not even being physically checked out by their doctors first. This could cause a host of problems because it is important for a doctor to be present and evaluate before someone is to take this pill.
Pennsylvania Governor Tom Wolf did the abortion industry’s bidding and vetoed a bill increasing access to telemedicine soley because it contained a requirement to follow the safety guidelines for all drugs on the FDA’s Risk Evaluations and Mitigation Strategies (REMS) list by delivering these drugs in-person in a healthcare facility. The REMS list includes Mifeprex, the abortion pill, because of the health risks it presents to women.
Stay tuned. We expect that the state legislature will be reintroducing a telemedicine bill next session and we will be fighting to include safeguards against its use for abortion.
By Josh Chambers, student at Olivet Nazarene University and PFI Intern